Search Results - "Pollack, Sarah F."

CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors by Vora, Sadhna R., Juric, Dejan, Kim, Nayoon, Mino-Kenudson, Mari, Huynh, Tiffany, Costa, Carlotta, Lockerman, Elizabeth L., Pollack, Sarah F., Liu, Manway, Li, Xiaoyan, Lehar, Joseph, Wiesmann, Marion, Wartmann, Markus, Chen, Yan, Cao, Z. Alexander, Pinzon-Ortiz, Maria, Kim, Sunkyu, Schlegel, Robert, Huang, Alan, Engelman, Jeffrey A.

“…Activation of the phosphoinositide 3-kinase (PI3K) pathway occurs frequently in breast cancer. However, clinical results of single-agent PI3K inhibitors have…”
Get full text

Cannabidiol as a new treatment for drug‐resistant epilepsy in tuberous sclerosis complex by Hess, Evan J., Moody, Kirsten A., Geffrey, Alexandra L., Pollack, Sarah F., Skirvin, Lauren A., Bruno, Patricia L., Paolini, Jan L., Thiele, Elizabeth A.

“…Summary Objective Tuberous sclerosis complex (TSC) is an autosomal‐dominant genetic disorder with highly variable expression. The most common neurologic…”
Get full text

BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors by Faber, Anthony C, Corcoran, Ryan B, Ebi, Hiromichi, Sequist, Lecia V, Waltman, Belinda A, Chung, Euiheon, Incio, Joao, Digumarthy, Subba R, Pollack, Sarah F, Song, Youngchul, Muzikansky, Alona, Lifshits, Eugene, Roberge, Sylvie, Coffman, Erik J, Benes, Cyril H, Gómez, Henry L, Baselga, José, Arteaga, Carlos L, Rivera, Miguel N, Dias-Santagata, Dora, Jain, Rakesh K, Engelman, Jeffrey A

“…Cancers with specific genetic mutations are susceptible to selective kinase inhibitors. However, there is a wide spectrum of benefit among cancers harboring…”
Get more information

Drug–drug interaction between clobazam and cannabidiol in children with refractory epilepsy by Geffrey, Alexandra L., Pollack, Sarah F., Bruno, Patricia L., Thiele, Elizabeth A.

“…Summary Objective Under an expanded access investigational new drug (IND) trial, cannabidiol (CBD) is being studied as a possible adjuvant treatment of…”
Get full text

Cannabidiol in treatment of refractory epileptic spasms: An open-label study by Herlopian, Aline, Hess, Evan J., Barnett, James, Geffrey, Alexandra L., Pollack, Sarah F., Skirvin, Lauren, Bruno, Patricia, Sourbron, Jo, Thiele, Elizabeth A.

“…This study aimed to evaluate clinical efficacy and safety of purified pharmaceutical cannabidiol (CBD) as an adjunctive therapy in refractory childhood-onset…”
Get full text

Myoclonus in Angelman syndrome by Pollack, Sarah F., Grocott, Olivia R., Parkin, Kimberly A., Larson, Anna M., Thibert, Ronald L.

“…Angelman syndrome (AS) is a neurogenetic imprinting disorder caused by loss of the maternally inherited Ube3a gene and is characterized by generalized…”
Get full text

Primary intestinal lymphangiectasia treated with rapamycin in a child with tuberous sclerosis complex (TSC) by Pollack, Sarah F., Geffrey, Alexandra L., Thiele, Elizabeth A., Shah, Uzma

“…Primary intestinal lymphangiectasia (PIL) is a rare protein‐losing enteropathy characterized by a congenital malformation of the lymphatic vessels of the small…”
Get full text

Gastrointestinal problems in 15q duplication syndrome by Shaaya, Elias A, Pollack, Sarah F, Boronat, Susana, Davis-Cooper, Shelby, Zella, Garrett C, Thibert, Ronald L

“…Abstract Chromosome 15q duplication syndrome (Dup15q syndrome) is a neurodevelopmental disorder involving copy number gains of the maternal chromosome…”
Get full text